Clarius Group LLC Has $471,000 Position in CME Group Inc. (NASDAQ:CME)


Share on StockTwits

Clarius Group LLC increased its holdings in shares of CME Group Inc. (NASDAQ:CME) by 26.6% during the 1st quarter, Holdings Channel.com reports. The fund owned 2,305 shares of the financial services provider’s stock after acquiring an additional 485 shares during the period. Clarius Group LLC’s holdings in CME Group were worth $471,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. Stratos Wealth Advisors LLC acquired a new stake in shares of CME Group during the 1st quarter valued at about $251,000. Stratos Wealth Partners LTD. boosted its position in shares of CME Group by 6.0% during the 1st quarter. Stratos Wealth Partners LTD. now owns 1,581 shares of the financial services provider’s stock valued at $323,000 after acquiring an additional 89 shares in the last quarter. Usca Ria LLC boosted its position in CME Group by 720.1% in the first quarter. Usca Ria LLC now owns 12,514 shares of the financial services provider’s stock valued at $2,556,000 after buying an additional 10,988 shares in the last quarter. AE Wealth Management LLC boosted its position in CME Group by 8.8% in the first quarter. AE Wealth Management LLC now owns 2,130 shares of the financial services provider’s stock valued at $435,000 after buying an additional 172 shares in the last quarter. Finally, Mosaic Family Wealth LLC acquired a new position in CME Group in the first quarter valued at about $210,000. Institutional investors and hedge funds own 83.88% of the company’s stock.

A number of equities analysts have commented on CME shares. Bank of America upgraded shares of CME Group from a “neutral” rating to a “buy” rating and boosted their price target for the company from $200.00 to $220.00 in a research report on Tuesday, March 30th. Citigroup reduced their price target on shares of CME Group from $240.00 to $235.00 in a research report on Thursday, April 29th. Zacks Investment Research lowered shares of CME Group from a “buy” rating to a “hold” rating and set a $205.00 price target on the stock. in a research report on Thursday, January 7th. Deutsche Bank Aktiengesellschaft lowered shares of CME Group from a “buy” rating to a “hold” rating and set a $196.00 target price on the stock. in a research report on Friday, January 8th. They noted that the move was a valuation call. Finally, Keefe, Bruyette & Woods upgraded shares of CME Group from an “underperform” rating to a “market perform” rating and upped their target price for the stock from $181.00 to $197.00 in a research report on Monday, March 1st. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and six have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $196.20.

In other news, Director Bryan T. Durkin sold 11,000 shares of the company’s stock in a transaction that occurred on Friday, February 19th. The shares were sold at an average price of $195.58, for a total value of $2,151,380.00. Following the completion of the transaction, the director now owns 74,650 shares in the company, valued at $14,600,047. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Dennis Suskind sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, February 12th. The shares were sold at an average price of $183.32, for a total transaction of $183,320.00. Following the completion of the transaction, the director now owns 2,565 shares of the company’s stock, valued at approximately $470,215.80. The disclosure for this sale can be found here. Insiders sold 23,000 shares of company stock valued at $4,528,390 in the last ninety days. Insiders own 1.20% of the company’s stock.

Shares of NASDAQ:CME opened at $203.70 on Tuesday. CME Group Inc. has a 52 week low of $146.89 and a 52 week high of $216.75. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market capitalization of $73.13 billion, a PE ratio of 33.95 and a beta of 0.46. The company has a 50 day moving average price of $205.35 and a two-hundred day moving average price of $187.74.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, April 28th. The financial services provider reported $1.79 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.75 by $0.04. CME Group had a net margin of 43.68% and a return on equity of 9.22%. The firm had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.22 billion. During the same quarter in the prior year, the firm earned $2.33 earnings per share. The business’s quarterly revenue was down 17.7% on a year-over-year basis. On average, sell-side analysts forecast that CME Group Inc. will post 6.69 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Thursday, March 25th. Shareholders of record on Wednesday, March 10th were paid a $0.90 dividend. This represents a $3.60 annualized dividend and a yield of 1.77%. The ex-dividend date was Tuesday, March 9th. This is an increase from CME Group’s previous quarterly dividend of $0.85. CME Group’s dividend payout ratio is presently 52.94%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products through its electronic trading platforms, open outcry, and privately negotiated transactions.

Featured Story: Diversification Important in Investing

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.